Hammer’s Managing Director, Daniel Thomas, said:
“The focus of the 2023 MIEJV exploration program has been significantly expanded to include the vast opportunities spread across the four MIEJV areas. Baseline geophysical and geochemical surveys have established several prospective anomalies, which have now matured into drill-ready targets.“An initial drilling program is now underway that will target prospective horizons at Prince of Wales, Thunderer and the unexplained EM anomaly at Toby.
“The Prince of Wales prospect is intriguing, with abundant copper anomalism, small- scale workings and a prime position between the two large active fault structures in the region – the Fountain Range and Pilgrim faults.
The current drilling program adds another dimension to the Company’s pending news-flow and offers shareholders further exposure to high-quality copper and gold drill targets.
- Forums
- ASX - By Stock
- Hmmm now what's happening here
Hammer’s Managing Director, Daniel Thomas, said:“The focus of...
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HMX (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.8¢ |
Change
-0.006(13.6%) |
Mkt cap ! $33.68M |
Open | High | Low | Value | Volume |
4.3¢ | 4.3¢ | 3.8¢ | $98.65K | 2.470M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 43460 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.8¢ | 34368 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 43460 | 0.037 |
2 | 64000 | 0.036 |
4 | 734717 | 0.035 |
1 | 100000 | 0.034 |
2 | 901515 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.038 | 34368 | 1 |
0.040 | 85000 | 1 |
0.041 | 48640 | 1 |
0.044 | 205000 | 2 |
0.045 | 458805 | 1 |
Last trade - 15.50pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
3.9¢ |
  |
Change
-0.006 ( 11.4 %) |
|||
Open | High | Low | Volume | ||
4.2¢ | 4.2¢ | 3.9¢ | 490927 | ||
Last updated 13.11pm 06/05/2024 ? |
Featured News
HMX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online